Clinical trial · Observational
Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers
Cross-sectional Study of Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers
NCT00634816CI-TRIAL-00010473completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Specific subgroups of children who survive treatment for childhood malignancies have been shown to develop relative osteopenia following chemotherapy and are felt to be at risk for developing osteoporosis later in life due to their inability to reach peak bone mass during childhood.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Regional Osteoporosis as a Result of Chemotherapy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| DXA Scan | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Chemotherapy recipients
- description
- Subjects who have undergone chemotherapy will receive DXA scan
- interventionNames
- Radiation: DXA Scan
Primary outcomes (1)
- measure
- Osteoporosis after chemotherapy
- timeFrame
- April 2003-April 2006
- description
- Does chemotherapy increase the risk of osteoporosis in patients
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 16 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * Patients from the SUNY Upstate Medical Center Pediatric Oncology Long-term Survivor Clinic who were treated for solid tumors and lymphomas with chemotherapy beginning at age less than 16 will be recruited for participation. Patients must be less than 40 years of age to participate. Exclusion Criteria: * Patients treated for Acute Lymphocytic Leukemia (ALL) and those who received cranial irradiation or total body irradiation (groups already known to be at high risk for osteoporosis) will be excluded. In addition, any patient who received non-autologous bone marrow transplant will be excluded, as these patients may have graft versus host disease (also known to be associated with osteopenia).
References
Publications (0)
Data not yet available
No reference posted for this study.